Zimmer Biomet Holdings ROA 2006-2018 | ZBH

Current and historical return on assets (ROA) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Zimmer Biomet Holdings ROA for the three months ending September 30, 2018 was 5.95%.
Zimmer Biomet Holdings ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $1.75B $25.38B 6.74%
2018-06-30 $1.69B $25.49B 6.43%
2018-03-31 $1.69B $27.18B 6.37%
2017-12-31 $1.81B $26.01B 6.85%
2017-09-30 $0.65B $26.42B 2.45%
2017-06-30 $0.71B $26.46B 2.66%
2017-03-31 $0.50B $26.99B 1.86%
2016-12-31 $0.31B $26.68B 1.16%
2016-09-30 $0.36B $27.04B 1.37%
2016-06-30 $0.23B $25.97B 0.86%
2016-03-31 $0.08B $26.30B 0.31%
2015-12-31 $0.15B $27.16B 0.59%
2015-09-30 $0.17B $26.69B 0.83%
2015-06-30 $0.32B $27.20B 2.00%
2015-03-31 $0.67B $17.19B 5.81%
2014-12-31 $0.72B $9.66B 7.52%
2014-09-30 $0.83B $9.67B 8.64%
2014-06-30 $0.81B $9.64B 8.52%
2014-03-31 $0.78B $9.38B 8.37%
2013-12-31 $0.78B $9.58B 8.48%
2013-09-30 $0.68B $9.36B 7.49%
2013-06-30 $0.70B $9.10B 7.88%
2013-03-31 $0.77B $8.75B 8.70%
2012-12-31 $0.76B $9.01B 8.64%
2012-09-30 $0.76B $8.78B 8.81%
2012-06-30 $0.77B $8.62B 9.12%
2012-03-31 $0.76B $8.60B 9.09%
2011-12-31 $0.76B $8.52B 9.21%
2011-09-30 $0.64B $8.20B 7.86%
2011-06-30 $0.64B $8.25B 7.90%
2011-03-31 $0.60B $8.12B 7.52%
2010-12-31 $0.60B $8.00B 7.54%
2010-09-30 $0.72B $8.00B 9.12%
2010-06-30 $0.68B $7.83B 8.70%
2010-03-31 $0.72B $7.82B 9.38%
2009-12-31 $0.72B $7.79B 9.52%
2009-09-30 $0.73B $7.65B 9.87%
2009-06-30 $0.80B $7.46B 10.96%
2009-03-31 $0.81B $7.23B 11.40%
2008-12-31 $0.85B $7.24B 12.05%
2008-09-30 $0.95B $7.08B 13.71%
2008-06-30 $0.78B $6.94B 11.54%
2008-03-31 $0.78B $6.92B 11.89%
2007-12-31 $0.77B $6.63B 12.18%
2007-09-30 $0.76B $6.37B 12.20%
2007-06-30 $0.89B $6.32B 14.70%
2007-03-31 $0.86B $6.10B 14.40%
2006-12-31 $0.84B $5.97B 14.05%
2006-09-30 $0.79B $5.91B 13.44%
2006-06-30 $0.78B $5.96B 13.36%
2006-03-31 $0.77B $5.92B 13.43%
2005-12-31 $0.73B $5.72B 13.06%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.421B $7.824B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $126.569B 18.92
Abbott Laboratories (ABT) United States $122.855B 24.89
Stryker (SYK) United States $63.182B 23.82
Boston Scientific (BSX) United States $49.097B 24.81
Baxter (BAX) United States $34.600B 22.34
Smith & Nephew SNATS (SNN) United Kingdom $16.589B 0.00
ResMed (RMD) United States $15.674B 29.89
Perrigo (PRGO) Ireland $8.142B 12.36
Bio-Rad Laboratories (BIO) United States $7.677B 49.09
Canopy Growth (CGC) Canada $7.290B 0.00
Hill-Rom Holdings (HRC) United States $6.241B 19.53
Aurora Cannabis (ACB) Canada $5.730B 30.26
Haemonetics (HAE) United States $5.332B 46.90
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.752B 26.48
Hutchison China MediTech (HCM) China $4.204B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.765B 0.00
Neogen (NEOG) United States $3.198B 48.43
Agios Pharmaceuticals (AGIO) United States $3.093B 0.00
NuVasive (NUVA) United States $2.886B 26.85
National Vision Holdings (EYE) United States $2.497B 48.30
NxStage Medical (NXTM) United States $1.925B 0.00
Quidel (QDEL) United States $1.917B 24.99
Phibro Animal Health (PAHC) United States $1.327B 18.78
Aphria (APHA) $1.306B 0.00
AtriCure (ATRC) United States $1.204B 0.00
Cardiovascular Systems (CSII) United States $0.991B 1428.00
VAREX IMAGING (VREX) United States $0.918B 18.37
PetIQ (PETQ) United States $0.886B 22.96
Meridian Bioscience (VIVO) United States $0.778B 24.80
Surmodics (SRDX) United States $0.766B 116.65
OraSure Technologies (OSUR) United States $0.752B 42.35
Cerus (CERS) United States $0.726B 0.00
MacroGenics (MGNX) United States $0.693B 0.00
Omeros (OMER) United States $0.687B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.655B 21.00
Lantheus Holdings (LNTH) United States $0.652B 20.17
NanoString Technologies (NSTG) United States $0.527B 0.00
LeMaitre Vascular (LMAT) United States $0.502B 24.65
Owens & Minor (OMI) United States $0.433B 4.90
Quanterix (QTRX) United States $0.433B 0.00
TG Therapeutics (TGTX) United States $0.414B 0.00
Insys Therapeutics (INSY) United States $0.385B 0.00
Evolus (EOLS) United States $0.375B 0.00
VAPOTHERM INC (VAPO) United States $0.350B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.90
Cytosorbents (CTSO) United States $0.295B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.243B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.207B 279.25
Rockwell Medical (RMTI) United States $0.172B 0.00
Chimerix (CMRX) United States $0.167B 0.00
Fonar (FONR) United States $0.135B 6.77
Imprimis Pharmaceuticals (IMMY) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
United-Guardian (UG) United States $0.079B 16.53
Female Health (VERU) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.27
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.052B 0.00
Neurotrope (NTRP) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00